Effect of TGFβ1 and TIMP2 on disease activity in asthma and COPD

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 2, 2010, Pages 79-86

  Ghanei, Mostafa ^a   Ghalejooghi, Navid Abolfath Zade ^a   Nourani, Mohammad Reza ^a   Harandi, Ali Amini ^a   Fooladi, Abbas Ali Imani ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asthma; COPD; TGF 1; TIMP2

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE FREE INTERVAL; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SPUTUM ANALYSIS; AIRWAY REMODELING; GENETICS; MAXIMAL EXPIRATORY FLOW; MIDDLE AGED; PHYSIOLOGY;

ADULT; AIRWAY REMODELING; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956823055     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kariyawasam HH, Robinson DS. The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol 2007; 19(6):681-6.
2. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17(4):519-28.
3. Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholz D, Gillery P, Emonard H, Nagler A, Maquart FA. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci U S A 1999; 96(17):9660-5.
4. Janette K. Burgess , Claudia Ceresa, Simon R. Johnson, Varsha Kanabar, et al. Tissue and matrix influences on airway smooth muscle function. Pulm Pharmacol Ther 2009:379-87
5. GINA (2006) Global Strategy for Asthma Management and Prevention: GINA executive summary. Eur Respir J 2008; 31(1):143-78.
6. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 2004; 287(6):L1160-4.
7. Vonk JM, Postma DS, Boezen HM, Grol MH, Schouten JP, Koeter GH, et al. Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 59(11):925-9.
8. Standardization of Spirometry, 1994 Update American Thoracic Society. Am J Respir Crit Care Med 1995: 152(3):1107-36.
9. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J (1992) Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47(1):25-9.
10. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154(2 Pt 1):308-17.
11. Kelly MM, Hargreave FE, Cox G. A method to preserve sputum for delayed examination. Eur Respir J 2003; 22(6):996-1000.
12. Reilly John J, Silverman Edwin K. Chronic Obstructive Pulmonary Disease.In: Fauci Anthony S,Braunwald Eugene, Kasper Dennis L, Hauser Stephen L, Longo Dan L, Jameson Larry , Loscalzo Joseph, editors. Harrison's principle of internal medicine. USA: McGraw-Hill 2008: 1635-1643.
13. Bossé Y, Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir Res 2007; 8:66.
14. Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, van der Geld YM, et al. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J 2006; 28(3):533-41.
15. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645-53.
16. Bienkowski RS, Gotkin MG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995; 209(2):118-40.
17. Camoretti-Mercado B, Solway J. Transforming growth factor-beta1 and disorders of the lung. Cell Biochem Biophys 2005; 43(1):131-48.
18. Hara K, Hasegawa T, Ooi H, Koya T, Tanabe Y, Tsukada H, et al. Inhibitory role of eosinophils on cell surface plasmin generation by bronchial epithelial cells: inhibitory effects of transforming growth factor beta. Lung 2001; 179(1):9-20.
19. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006; 27(1):208-29.
20. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999; 21(6):658-65.
21. Wenzel SE, Trudeau JB, Barnes S, Zhou X, Cundall M, Westcott JY, et al. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 2002; 169(8):4613-9.
22. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003; 162(2):533-46.
23. Gerwin BI, Keski-Oja J, Seddon M, Lechner JF, Harris CC. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am J Physiol 1990; 259(4 Pt 1):L262-9.
24. Kordula T, Güttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, et al. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1. FEBS Lett 1992; 313(2):143-7.
25. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269(12):9352-60.
26. Bullard KM, Cass DL, Banda MJ, Adzick NS. Transforming growth factor beta-1 decreases interstitial collagenase in healing human fetal skin. J Pediatr Surg 1997; 32(7):1023-7.
27. Ziora D, Dworniczak S, Kozielski J. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2008; 59(Suppl 6):809-17.
28. Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y, et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001; 18(5):748-52.
29. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2002; 30(2):98-102.
30. Lowrey GE, Henderson N, Blakey JD, Corne JM, Johnson SR. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med 2008; 102(6):845-51.
31. Kelly MM, Leigh R, Bonniaud P, Ellis R, Wattie J, Smith MJ, et al. Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am J Respir Cell Mol Biol 2005; 32(2):99-107.
32. Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 2008; 102(6):825-30.
33. Meisler N, Keefer KA, Ehrlich HP, Yager DR, Myers-Parrelli J, Cutroneo KR. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol 1997; 108(3):285-9.